Cagrilintide
Cagrilintide is a long-acting compound that mimics amylin, a hormone normally released alongside insulin after eating. Amylin sends signals that help the brain recognize fullness and slows the movement of food out of the stomach. By activating these pathways, cagrilintide can reduce appetite and food intake, making it a promising treatment being studied for weight management. It has also been researched in combination with medicines that act on GLP-1 receptors. Its most noticeable effects relate to fullness and digestion, which also explains why nausea and other stomach-related symptoms can occur.
Over $150
Protection
256-bit SSL
Overnight shipping available · Cold-chain packaging included
Technical Specifications
Molecular Profile
Storage Conditions
Avoid freeze/thaw cycles · Protect from light · Keep refrigerated
You may also like
⚠ For laboratory and research use only. Not for human consumption.
Cagrilintide is supplied exclusively as a reagent for legitimate in vitro laboratory and research purposes. This product is not a drug, food, or cosmetic, is not approved by the FDA, and is not intended for human or veterinary use. UPRIME LABS makes no therapeutic, medical or health claims. Purchasers are responsible for complying with all applicable laws and regulations.